2010
DOI: 10.1016/j.jopan.2009.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Preoperative Rectal Indomethacin on Postoperative Pain Reduction After Open Cholecystectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Of the included trials, 89 did not mention SAEs, 28–116 and two trials mentioned potential SAEs without specifying in which intervention group these events occurred 117,118 . Lack of response to email inquiries meant these studies could not provide relevant or quantifiable data for any of our outcomes.…”
Section: Resultsmentioning
confidence: 99%
“…Of the included trials, 89 did not mention SAEs, 28–116 and two trials mentioned potential SAEs without specifying in which intervention group these events occurred 117,118 . Lack of response to email inquiries meant these studies could not provide relevant or quantifiable data for any of our outcomes.…”
Section: Resultsmentioning
confidence: 99%
“…To date, laparoscopy cholecystectomy (LC) is the approach of choice for acute cholecystitis and has replaced open cholecystectomy (OC) [10], because LC reduces postoperative morbidity and hospital stay. However, OC is the current treatment of care for others [11]- [16] and OC has been associated with severe postoperative pain [17] [18]. However, the intensity of pain due to cholecystectomy in diabetic patients to date remains unknown.…”
Section: Introductionmentioning
confidence: 99%
“…[17][18][19][20] In this issue of the Journal of PeriAnesthesia Nursing, researchers from Iran present the findings of their excellent study on the use of preoperative rectal indomethacin in adults undergoing open cholecystectomy. 21 The researchers selected indomethacin primarily because it is widely available and inexpensive when compared with other nonopioid analgesics. They appropriately point out that indomethacin is associated with a higher risk of GI toxicity than some of the other nonopioids, and emphasize the need for appropriate patient selection criteria to prevent complications.…”
mentioning
confidence: 99%